Entropy Technologies LP purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,800 shares of the financial services provider’s stock, valued at approximately $202,000.
Other large investors have also recently added to or reduced their stakes in the company. Louisiana State Employees Retirement System increased its position in shares of Trupanion by 2.8% during the second quarter. Louisiana State Employees Retirement System now owns 18,200 shares of the financial services provider’s stock valued at $535,000 after purchasing an additional 500 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares during the period. WINTON GROUP Ltd boosted its position in shares of Trupanion by 1.9% during the 2nd quarter. WINTON GROUP Ltd now owns 37,673 shares of the financial services provider’s stock valued at $1,108,000 after acquiring an additional 685 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in shares of Trupanion by 2.0% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider’s stock valued at $1,188,000 after acquiring an additional 830 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System increased its stake in Trupanion by 12.6% in the first quarter. State Board of Administration of Florida Retirement System now owns 12,726 shares of the financial services provider’s stock valued at $351,000 after acquiring an additional 1,420 shares during the period.
Insider Buying and Selling at Trupanion
In other Trupanion news, Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the transaction, the director now directly owns 131,513 shares in the company, valued at approximately $6,926,789.71. This represents a 1.50 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This represents a 6.98 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,124 shares of company stock worth $482,981. Insiders own 5.50% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Report on Trupanion
Trupanion Price Performance
Trupanion stock opened at $52.76 on Monday. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The firm has a market cap of $2.23 billion, a P/E ratio of -164.88 and a beta of 1.69. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The business’s fifty day moving average is $48.23 and its two-hundred day moving average is $38.33.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. The business had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. Trupanion’s revenue was up 14.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.10) earnings per share. Equities research analysts forecast that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- How to Invest in Biotech Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Profitably Trade Stocks at 52-Week Highs
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.